CSLLY   $99.75  0.42% Market Closed

CSL Ltd
Last Events:

2023-03-30 Trend pattern changed from канал to нисходящий треугольник.

2023-03-30 Signal in Stochastic changed from bullish reversal to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: main and signal line crossing.

2023-03-30 Signal in MACD changed from bearish reversal to bullish reversal. Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: exit from the oversold zone.

2023-03-30 Signal in RSI changed from bullish recovery to bearish recovery. RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

2023-03-30 Signal in EMA100 changed from bullish reversal to bearish reversal. 2023-03-06 the price crossed down the moving average line and trying to form a short-term downside trend.

2023-03-30 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-02-21 the price crossed down the moving average line and demonstrates a downside trend.

2023-03-30 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-02-16 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-03-30 Trend Power changed from slow to almost flat.


Current temperature: 2.54
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Buy Buy Buy
rsi ActivelyBuy - Buy
macd - - -
stoch - - -
ma20 ActivelyBuy ActivelyBuy -
ma50 - - -
ma100 - Buy -
Candlestick PatternApril 14, 2023 Three Gaps Up - pattern is a made up of four white candlesticks. Pattern appears on a downtrend and consists of three consecutive days each gapping higher on the open. Considered to be a bearish reversal pattern.
ISIN US12637N2045
ceo Dr. Paul F. McKenzie Ph.D.
Website https://www.csl.com.au
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.